Trial of MSC1936369B in Subjects With Solid Tumors

NCT00982865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Cancer

Interventions

DRUG: MSC1936369B
DRUG: MSC1936369B
DRUG: MSC1936369B
DRUG: MSC1936369B

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]